John Martin Docherty - Net Worth and Insider Trading

John Martin Docherty Net Worth

The estimated net worth of John Martin Docherty is at least $61,708 dollars as of 2024-05-21. John Martin Docherty is the President of Lexaria Bioscience Corp and owns about 20,166 shares of Lexaria Bioscience Corp (LEXX) stock worth over $61,708. Details can be seen in John Martin Docherty's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John Martin Docherty has not made any transactions after 2016-04-15 and currently still holds the listed stock(s).

Transaction Summary of John Martin Docherty

To

John Martin Docherty Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Martin Docherty owns 1 companies in total, including Lexaria Bioscience Corp (LEXX) .

Click here to see the complete history of John Martin Docherty’s form 4 insider trades.

Insider Ownership Summary of John Martin Docherty

Ticker Comapny Transaction Date Type of Owner
LEXX Lexaria Bioscience Corp 2016-04-15 director & 10 percent owner

John Martin Docherty Latest Holdings Summary

John Martin Docherty currently owns a total of 1 stock. John Martin Docherty owns 20,166 shares of Lexaria Bioscience Corp (LEXX) as of April 15, 2016, with a value of $61,708.

Latest Holdings of John Martin Docherty

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LEXX Lexaria Bioscience Corp 2016-04-15 20,166 3.06 61,708

Holding Weightings of John Martin Docherty


John Martin Docherty Form 4 Trading Tracker

According to the SEC Form 4 filings, John Martin Docherty has made a total of 0 transactions in Lexaria Bioscience Corp (LEXX) over the past 5 years. The most-recent trade in Lexaria Bioscience Corp is the acquisition of 7,000 shares on April 15, 2016, which cost John Martin Docherty around $21,000.

Insider Trading History of John Martin Docherty

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Martin Docherty Trading Performance

GuruFocus tracks the stock performance after each of John Martin Docherty's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Martin Docherty is 11.86%. GuruFocus also compares John Martin Docherty's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Martin Docherty within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John Martin Docherty's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John Martin Docherty

Average Return

Average return per transaction

Outperforming Transactions

1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.58
Relative Return to S&P 500(%) 4.47

John Martin Docherty Ownership Network

Ownership Network List of John Martin Docherty

No Data

Ownership Network Relation of John Martin Docherty


John Martin Docherty Owned Company Details

What does Lexaria Bioscience Corp do?

Who are the key executives at Lexaria Bioscience Corp?

John Martin Docherty is the director & 10 percent owner of Lexaria Bioscience Corp. Other key executives at Lexaria Bioscience Corp include Chief Financial Officer Gregory Downey , director & 10 percent owner & CEO Christopher Bunka , and Secretary Vanessa Carle .

Lexaria Bioscience Corp (LEXX) Insider Trades Summary

Over the past 18 months, John Martin Docherty made no insider transaction in Lexaria Bioscience Corp (LEXX). Other recent insider transactions involving Lexaria Bioscience Corp (LEXX) include a net purchase of 1,500 shares made by Catherine C. Turkel ,

In summary, during the past 3 months, insiders sold 0 shares of Lexaria Bioscience Corp (LEXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexaria Bioscience Corp (LEXX) were sold and 1,500 shares were bought by its insiders, resulting in a net purchase of 1,500 shares.

Lexaria Bioscience Corp (LEXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lexaria Bioscience Corp Insider Transactions

No Available Data

John Martin Docherty Mailing Address

Above is the net worth, insider trading, and ownership report for John Martin Docherty. You might contact John Martin Docherty via mailing address: 23 Mikelen Drive, Port Perry A6 L9l 1v1.

Discussions on John Martin Docherty

No discussions yet.